TLR2 and cancer: In this regard, the cystine/glutamate antiporter xCT, and Toll-like Receptor 2 (TLR2) represent particularly interesting candidates, having a key role in cancer progression and therapy-resistance and being (over)expressed also in OSA [11,12,20,21,22,23,24,25,26].